Accendra Health Elects New Director Following Officer Departure
Accendra Health disclosed the election of a new board member and the departure of a principal officer in an 8-K filing. The changes alter the company's board composition and executive oversight effective immediately upon the filing date.
insidermonkey.comAccendra Health Inc. reported the departure of a principal officer and the election of a new director in a Form 8-K filed with the SEC on May 15, 2026.
The filing, submitted under Items 5.02 and 5.07, covers both the officer change and matters submitted to a vote of security holders. Accendra Health, a Virginia corporation with ticker ACH and CIK 0000075252, is a publicly traded entity required to report such events promptly under SEC rules.
Item 5.02 states the departure of a named principal officer, with the effective date listed as May 15, 2026. The filing does not disclose a cited cause for the departure. The same item reports the election of a new director to the board. Prior to the filing the board operated with its previous composition; the new state includes one additional director and the absence of the departed officer.
The changes took effect on the filing date of May 15, 2026.
The operational delta triggers standard follow-on requirements. The company must update its disclosures in subsequent periodic filings to reflect the new board and officer roster. Any compensatory arrangements connected to the departure, if material, require separate disclosure within four business days under Item 5.02(b) if not already detailed.
The election of the new director, approved by security holders per Item 5.07, confirms the vote results and resets the board's decision-making structure for governance and oversight matters. Downstream, the board must now act with its revised membership on any pending committee assignments, executive compensation decisions, or audit responsibilities.
Markets and regulators receive formal notice through this filing, allowing counterparties, auditors, and investors to update records without further delay.
This filing represents the latest board-level change for Accendra Health, a non-watchlist issuer whose prior 8-K disclosures have followed standard SEC timelines for officer and director events. The Form 8-K serves as the primary public record, with the full text available under accession number 0001104659-26-061888.
Coverage spread
Substrate’s article above is written from the primary record. Below: how mainstream outlets reported the same event.
No mainstream coverage of this story has surfaced yet.
Transparency Panel
Related Stories
ibtimes.comSEC Chair Paul Atkins Says Congress Will Pass Crypto Legislation
SEC Chair Paul Atkins stated he is confident Congress will pass crypto market structure legislation. He added that President Trump will sign the bill into law.
asiaone.comIran Says Strait of Hormuz Management Belongs to Iran and Oman
Iran's Foreign Ministry spokesperson stated that control of the Strait of Hormuz must be decided solely by Iran and Oman. The spokesperson also said no agreement has been reached with the United States and that current focus remains on ending the war.
cnbc.comFed Official Highlights Regulatory Barriers to AI Productivity Gains
A Federal Reserve official stated that productivity growth remains key to economic expansion and that regulatory hurdles are the main obstacle to sustained gains from artificial intelligence.